...the treatment of acute pain. The test is not intended to be used in patients being treated for chronic pain. The AvertD test is a prescription-use only genetic laboratory test...
...the treatment of acute pain. The test is not intended to be used in patients being treated for chronic pain. The AvertD test is a prescription-use only genetic laboratory test...
With dozens of manufacturers providing various types of diagnostic tests for COVID-19, several companies have created serological (antibody) tests. Many manufacturers have received Emergency Use Authorizations (EUA) for tests they...
The FDA issued an emergency use authorization (EUA) for LabCorp’s COVID-19 RT-PCR test to permit testing of samples self-collected by patients at home using a special home collection kit. Headlines...
...cultural fit. For a more in-depth look at how the IT talent shortage is affecting workers’ comp, see the Rxinformer article, Coming Up Short: IT Talent Woes in Workers’ Comp....
A breakdown of the diverse subcategories comprising dermatologicals prescribing and spend...
...risks inherent to opioid use in workers' comp populations, exploring how data aggregation, combined with systematically applied clinical logic, can reduce drug therapy risks and expose gaps in care. Dr....
...right to use marijuana. Nevada Assembly Bill No. 132 was signed into law earlier this June, prohibiting the denial of employment over the presence of marijuana in a drug screening test...
...more comprehensive approach, the Illinois Workers’ Compensation Commission issued an emergency ruling that offers coverage to first responders, healthcare workers, and other front-line workers, assuming COVID-19 arises out of the...
The National Comp Conference – formerly known as the National Workers’ Compensation and Disability Conference (NWCDC) – will be held from October 20-22 in Las Vegas, offering in-person and digital...
